
The Settlement Facility has released information about the status of claims processing and payments through NOV 30, 2011, The information is summarized below:
Through NOV 30, 2011, the SF-DCT has received
77,279 Proof of Manufacturer claim forms in Classes 5, 6.1 and 6.2 (Dow Corning Breast Implant Claims). Of this number,
65,431 or 84.68% have acceptable proof of at least one Dow Corning breast implant. Of the 65,431 Dow Corning breast implant claimants with acceptable proof of manufacturer, almost
34% (one-third) or 21,870 women have been approved for a Rupture claim for their Dow Corning silicone gel breast implant.
CLASS 5, 6.1 AND 6.2 (EXCLUSIVE OF NOI PAYMENTS)
(DOW CORNING BREAST IMPLANT CLAIMS)
| Claim Category
|
NUMBER OF CLAIMS
PAID THROUGH NOV 30, 2011 |
PERCENTAGE OF CLAIMS
APPROVED CLASS 5 | CLASS 6 |
TOTAL $$ PAID IN
CATEGORY THROUGH NOV 30, 2011 |
| RUPTURE |
21,870 |
71% | 40% |
$421,082,139.69 |
| EXPLANT |
28,449 |
99% | 96% |
$137,717,177.61 |
| EXPLANT ASSISTANCE |
597 |
92% | 80% |
$2,950,641.10 |
| INCREASED EXPLANT (6.2 ONLY) |
279 |
N/A | 92% |
$ 834,000.00 |
| EXPEDITED RELEASE |
23,110 |
92% | 87% |
$43,089,333.35 |
| DISEASE OPTION 1 |
27,708 |
83% | 68% |
$408,962,602.42 |
| DISEASE OPTION 2 |
1,387 |
29% | 14% |
$178,214,053.54 |
| TOTAL |
103,400 |
N/A |
$1,192,849,947.71 |
Class 7 – Silicone Gel Material Claims
Approximately 15,065 claimants in Class 7 – Silicone Gel Material Claims – have been approved for either an Expedited Release Payment ($600) or a Disease Cash-Out Offer ($3,000). Total payments to date from the Class 7 Fund are approximately $21.2 million. The total fund is $57.5 million NPV. The Settlement Facility continues to review Proof of Manufacturer claims in Class 7 and expects to complete all Proof of Manufacturer reviews within the next few months and they will begin to process Class 7 disease claims after that. We are doing everything we can to urge the Settlement Facility to expedite the Class 7 Proof of Manufacturer reviews. As Proof of Manufacturer (POM) claims are approved, the Settlement Facility will send either the Class 7 Expedited Release Payment to eligible claimants who selected this option or a Disease Cash-Out Offer to claimants who selected the disease review. There are approximately 127 Proof of Manufacturer files pending review, and 238 Disease claims pending review, mostly in Disease Option 1.
There is a number of pending
appeals before the Claims Administrator and Appeals Judge regarding the
marshaling requirement for certain Class 7 claimants.
No decision has been made on these appeals.
We will update you on this as soon as the information is
available.
CLASS 7 (SILICONE GEL MATERIAL CLAIMS)
| # Class 7 Forms Filed |
54,721 |
| Failed Prescreen - Ineligible Implant - Failed
Marshalling |
37,622 |
| Foreign Gel Claims Approved & Paid $600 |
657 |
| Expedited Release Claims Approved & Paid $600 |
6,984 |
| # of Disease Cash-Out Offers of $3,000 |
7,424 |
| TOTAL PAYMENTS OR CASH-OUT OFFERS |
15,065 |
| TOTAL # of Claims Paid (excluding those who rejected
the Cash-Out Offer) |
12,963 |
| TOTAL AMT PAID as of 11/30/2011 |
$21,397,717.39 |
Class 9 and 10 - Dow Corning Covered Other Products
Below is a chart showing the total number of Class 9 and 10 claims filed
and paid to date:
CLASS 9, 10.1 AND 10.2
DCC "COVERED" OTHER PRODUCTS
| CLAIM CATEGORY
|
NUMBER OF FORMS
FILED |
NUMBER OF CLAIMS
REVIEWED |
NUMBER OF CLAIMS
APPROVED |
# CLAIMS PAID 1ST
PAYMENT |
# CLAIMS PAID PREMIUM
PAYMENT |
PERCENTAGE OF CLAIMS
APPROVED FOR 1ST PAYMENT |
$ AMOUNT PAID 1ST
PAYMENT |
$ AMOUNT PAID PREMIUM
PAYMENT |
TOTAL PAID
|
| PROOF OF MANUFACTURER |
7224 |
7215 |
2617 |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
| EXPEDITED RELEASE |
3932 |
1582 |
1580 |
2018 |
N/A |
100% |
$1,911,995.10 |
N/A |
$1,911,395.10 |
| RUPTURE |
557 |
124 |
28 |
28 |
28 |
100% |
$136,000.00 |
$680,000.00 |
$816,000.00 |
| INFLAMMATORY FOREIGN BODY RESP. (TMJ, finger, wrist,
toe, knee & hip) |
1748 |
713 |
414 |
393 |
378 |
95% |
$2,000,125.00 |
$8,586,260.00 |
$10,586,385.00 |
| IMPLANT FAILURE (TMJ, finger wrist, toe knee, hip
& testicular) |
2323 |
832 |
111 |
104 |
112 |
94% |
$546,500.00 |
$2,614,115.00 |
$3,160,615.00 |
| TMJ ENHANCED |
1267 |
370 |
44 |
42 |
43 |
95% |
$529,500.00 |
$3,345,500.00 |
$3,875,000.00 |
| TOTALS |
17051 |
10836 |
4794 |
2585 |
561 |
TOTALS |
$5,124,120.10 |
$15,225,875.00 |
$20,349,395.10 |
NOI CLAIMS CLASS
5, 6.1 AND 6.2
| |
TOTAL FORMS FILED |
FORMS FILED WITH POM |
ACCEPTABLE POM |
APPROVED |
COMPLETE |
# CLAIMS PAID |
TOTAL AMT PAID |
| RUPTURE |
1,912 |
1,877 |
1,610 |
1,136 |
1,619 |
1,149 |
$21,215,624 |
| MEDICALLY CONTRAINDICATED |
18 |
17 |
15 |
2 |
10 |
0 |
0 |
| EXPLANT |
1,509 |
1,492 |
1,278 |
1,092 |
1,278 |
1,088 |
$5,277,618 |
| INCREASED EXPLANT |
304 |
304 |
299 |
113 |
299 |
111 |
333,000 |
| EAP |
271 |
266 |
212 |
40 |
47 |
36 |
$175,200 |
| TOTALS |
4,014 |
3,956 |
3,414 |
2,383 |
3,253 |
2,384 |
$27,001,441 |
11/30/2011 INCLUDES
NOI PAYMENTS (DOES NOT INCLUDE STALE CHECKS)
| |
RUPTURE |
EXPLANT |
INCREASED EXPLANT |
EXPLANT ASSISTANCE (EAP) |
EXPEDITED |
DISEASE |
MEDICAL CONDITIONS (IFBR, TMJ,
IMPLANT FAILURE) |
OTHER PRODUCTS PREMIUM PAYMENT |
TOTAL |
| CLASS 5 |
$425,318,162.94 |
$138,576,632.87 |
N/A |
$3,116,841.10 |
$39,777,899.50 |
$577,300,887.48 |
N/A |
N/A |
$1,184,090,423.89 |
| CLASS 6.1 |
$13,929,750.51 |
$4,302,362.44 |
N/A |
$9,000.00 |
$2,970,243.85 |
$7,547,218.48 |
N/A |
N/A |
$28,758,575.28 |
| CLASS 6.2 |
$3,472,000.00 |
$228,750.00 |
$1,167,000.00 |
$0.00 |
$98,000.00 |
$2,328,550.00 |
N/A |
N/A |
$7,294,300.00 |
| CLASS 6.2 2 |
N/A |
N/A |
N/A |
N/A |
$103,700.00 |
N/A |
N/A |
N/A |
$103,700.00 |
| CLASS 6.2 3 |
N/A |
N/A |
N/A |
N/A |
$228,000.00 |
N/A |
N/A |
N/A |
$228,000.00 |
| CLASS 7 |
N/A |
N/A |
N/A |
N/A |
$21,397,717.39 |
$0,00 |
N/A |
N/A |
$21,397,717.39 |
| CLASS 9 |
$130,000.00 |
N/A |
N/A |
N/A |
$1,757,145.10 |
N/A |
$2,856,500.00 |
$14,175,000.00 |
$18,918,645.10 |
| CLASS 10.2 / 10.2 |
$6,000.00 |
N/A |
N/A |
N/A |
$155,850.00 |
N/A |
$219,625.00 |
$1,050,875.00 |
$1,432,350.00 |
| Total |
$442,855,913.45 |
$143,107,745.31 |
$1,167,000.00 |
$3,125,841.10 |
$66,488,555.84 |
$587,176,655.96 |
$3,076,125.00 |
$15,225,875.00 |
$1,262,223,711.66 |
| |
|
|
|
|
|
|
|
|
|
| |
RUPTURE |
EXPLANT |
INCREASED EXPLANT |
EXPLANT ASSISTANCE (EAP) |
EXPEDITED |
DISEASE |
MEDICAL CONDITIONS (IFBR, TMJ,
IMPLANT FAILURE) |
OTHER PRODUCTS PREMIUM PAYMENT |
TOTAL |
| CLASS 5 |
21,408 |
28,008 |
N/A |
630 |
20,092 |
27,802 |
N/A |
N/A |
97,940 |
| CLASS 6.1 |
1,164 |
1,451 |
N/A |
3 |
2,485 |
714 |
N/A |
N/A |
5,817 |
| CLASS 6.2 |
496 |
125 |
390 |
0 |
140 |
579 |
N/A |
N/A |
1,730 |
| CLASS 6.2 2 |
N/A |
N/A |
N/A |
N/A |
87 |
N/A |
N/A |
N/A |
87 |
| CLASS 6.2 3 |
N/A |
N/A |
N/A |
N/A |
380 |
N/A |
N/A |
N/A |
380 |
| CLASS 7 |
N/A |
N/A |
N/A |
N/A |
12,963 |
0 |
N/A |
N/A |
12,963 |
| CLASS 9 |
26 |
N/A |
N/A |
N/A |
1,758 |
N/A |
475 |
497 |
2,756 |
| CLASS 10.2 / 10.2 |
2 |
N/A |
N/A |
N/A |
261 |
N/A |
64 |
64 |
391 |
| Total |
23,096 |
29,584 |
390 |
633 |
38,166 |
29,095 |
539 |
561 |
122,064 |

© 2010 Claimants' Advisory Committee. All Rights Reserved.
|